Trade Mark Journal No.2026/018 1 May 2026

UK00004368142 2 April 2026 (5)

XPHOZAH

Class 5: Pharmaceutical and medicinal preparations; prescription pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of hyperphosphatemia; pharmaceutical preparations for the treatment and prevention of kidney and cardiovascular diseases; pharmaceutical preparations for patients undergoing dialysis; pharmaceutical preparations for reducing serum phosphorus levels; phosphate absorption inhibitors; tablets for medical purposes.

Ardelyx, Inc.

Representative: Withers & Rogers LLP